Cite
Decker C, Yu ZF, Giugliani R, et al. Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Pediatr Rehabil Med. 2010;3(2):89-100doi: 10.3233/PRM-2010-0113.
Decker, C., Yu, Z. F., Giugliani, R., Schwartz, I. V., Guffon, N., Teles, E. L., Miranda, M. C., Wraith, J. E., Beck, M., Arash, L., Scarpa, M., Ketteridge, D., Hopwood, J. J., Plecko, B., Steiner, R., Whitley, C. B., Kaplan, P., Swiedler, S. J., Conrad, S., & Harmatz, P. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of pediatric rehabilitation medicine, 3(2), 89-100. https://doi.org/10.3233/PRM-2010-0113
Decker, Celeste, et al. "Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase." Journal of pediatric rehabilitation medicine vol. 3,2 (2010): 89-100. doi: https://doi.org/10.3233/PRM-2010-0113
Decker C, Yu ZF, Giugliani R, Schwartz IV, Guffon N, Teles EL, Miranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Ketteridge D, Hopwood JJ, Plecko B, Steiner R, Whitley CB, Kaplan P, Swiedler SJ, Conrad S, Harmatz P. Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Pediatr Rehabil Med. 2010;3(2):89-100. doi: 10.3233/PRM-2010-0113. PMID: 20634905; PMCID: PMC2904323.
Copy
Download .nbib